Propranolol propranolol portal hypertension cirrhosis study OBJECTIVE propranolol reduces hepatic portal pressure patients cirrhosis DESIGN randomized trial PATIENTS Fifty patients cirrhosis esophageal varices study INTERVENTION Twenty-one patients oral propranolol doses resting heart rate patients oral propranolol schedule oral mg day MEASUREMENTS Hepatic vein pressure gradient liver function splanchnic systemic hemodynamics months continuous therapy MAIN RESULTS months hepatic venous pressure gradient patients propranolol mm Hg CI mm Hg mm Hg CI mm Hg hepatic venous pressure gradient baseline value patients propranolol patients therapy significant decreases hepatic blood flow intrinsic clearance indocyanine green propranolol therapy therapy treatments similar reductions azygos blood flow cardiac output CONCLUSIONS long-term combined administration propranolol reduces portal pressure adverse effects hepatic perfusion liver function hemodynamic effect clinical efficacy controlled trials 